CD38

There are 248 papers on CD38 in aging research: 9 trials and 83 observational studies in people, 84 in animals, 27 in cells, 41 reviews. The newest story, Oct 22, 2026: “Blocking CD38 reduces lung transplant injury in mice”.

Gene

248 papers study it133 findings

HGNCNCBI GeneTaxon

10 new papers in 30 daysSee all 248 papers on CD38

At a glance

CD38 lowers NAD+ and increases inflammation and cellular senescence in mice; independent labs reproduce these changes, while a finding points the other way. A mouse study finds no clear lifespan effect of CD38 knockout in hSOD1-linked ALS models. One group reports human associations with dyslipidemia, fibrosis-related measures and lung disease.

133 findings in 84 papers from 2006 to 2026, 10 of them since April 2026

The findings reach people, from one lab or study; independent labs found the same change in cells and mice. 43 independent labs in 14 countries; 24 trials, 1 with no results posted.

“Mega-analysis of expression has identified CD38 and TNFRSF12A (p < 2.12e−8) as genes not yet explored in a context of senescence-COPD connection.”
TNFRSF12A and CD38 Contribute to a Vicious Circle for Chronic Obstructive Pulmonary Disease by Engaging Senescence PathwaysFrontiers in cell and developmental biology2020doi:10.3389/fcell.2020.00330

1 of its findings points the other way.

Cells and mice: replicated by independent labs. Humans: a single group. Worms or flies: nothing yet.
  • 43 independent labs in 14 countries
  • 1 finding against
  • 24 trials, 1 with no results posted
  • Funders: National Institutes of Health and others
  • 27 of 105 findings with company ties
  • 23 of 24 trials sponsored by developers of drugs aimed at it
  • Human trial9
  • Humans83
  • Animals84
  • Cells27
  • In silico3

Interventions

13

Nicotinamide riboside

downin cells1upin mice1

2 studies
  1. Nicotinamide riboside increases CD38 in mice (Apoe knockout mice on high-cholesterol diet).

    “In liver lysates, SIRT1 and lipoprotein receptors were decreased and CD38 increased in NR++”

    AnimalsApoe knockout mice on high-cholesterol dietliverNR++ (high dose)12 weeksmales

    NAD⁺ boosting increases atherosclerotic plaques and inflammation in Apoe knockout mice

    Atherosclerosis

  2. Nicotinamide riboside inhibits CD38 in cells (covalent ribosyl-ester bond with glutamate 226 at the active site).

    “NR exhibits marked inhibitory activity against CD38 by forming a stable ribosyl-ester bond with the glutamate residue 226 at the active site.”

    Cellscovalent ribosyl-ester bond with glutamate 226 at the active site

    Nicotinamide Riboside and CD38: Covalent Inhibition and Live-Cell Labeling

    JACS Au

More on Nicotinamide riboside

Hypoxia-conditioned mesenchymal stem cell secretome

downin rats1

1 study
  1. Hypoxia-conditioned mesenchymal stem cell secretome decreases CD38 in STZ-induced diabetic rats (12.72 ± 2.65 (P1) and 8.43 ± 1.01 (P2) vs 19.07 ± 2.70 (C)).

    “CD38 expression significantly decreased in P1 (12.72 ± 2.65) and P2 (8.43 ± 1.01) compared to C (19.07 ± 2.70).”

    Animalsin STZ-induced diabetic ratsbrain

    Hypoxia-conditioned MSC secretome attenuates CD38 expression and cellular senescence in a diabetic rat brain model

    Asia-Pacific Journal of Molecular Biology and Biotechnology

More on Hypoxia-conditioned mesenchymal stem cell secretome

Apigenin

downin reviews1

1 study
  1. Apigenin inhibits CD38.

    “apigenin as a longevity-oriented functional food bioactive that targets senescent cells through senomorphic mechanisms and NAD+ modulation via CD38 inhibition”

    Review

    Apigenin as a bioactive compound for longevity: Targets and mechanisms in senescent cells

    Bioactive Compounds in Health and Disease

More on Apigenin

CVN14

downin cells1

1 study
  1. CVN14 inhibits CD38 in cells.

    “culminating in the identification of CVN14, a potent, selective, and brain-penetrant tool molecule”

    Cells

    Discovery of Potent, Selective, and Brain-Penetrant Small Molecule CD38 Inhibitors

    ACS medicinal chemistry letters

More on CVN14

High-protein diet

upin mice1

1 study
  1. High-protein diet increases CD38 in macrophages.

    “HP intake triggers macrophage-specific upregulation of CD38 (a key NAD+ hydrolase)”

    Animalsin macrophagesmacrophage

    Long-term high-protein diet intake accelerates adipocyte senescence through macrophage CD38-mediated NAD⁺ depletion

    Molecular metabolism

More on High-protein diet

Oral pathogen infection

upin mouse cells1

1 study
  1. Oral pathogen infection increases CD38 in old versus young macrophages.

    “old murine macrophages significantly enhanced CD38 and reduced NAD+ levels 24 h after Aa or Pg infection compared to young controls”

    Cellsin old versus young macrophagesmacrophage24 h

    Inhibition of CD38 by 78c Enhanced NAD⁺, Alleviated Inflammation, and Decreased Oxidative Stress in Old Murine Macrophages Induced by Oral Pathogens

    International journal of molecular sciences

More on Oral pathogen infection

Quercetin + enoxolone

downin human cells1

1 study
  1. Quercetin + enoxolone inhibits CD38 in human cells.

    “using a phytochemical complex consisting of quercetin, and enoxolone through inhibition of CD38”

    Cellsphytochemical complex

    Novel Approach to Skin Anti-Aging: Boosting Pharmacological Effects of Exogenous Nicotinamide Adenine Dinucleotide (NAD⁺) by Synergistic Inhibition of CD38 Expression

    Cells

More on Quercetin + enoxolone

Parishin

downin mice1

1 study
  1. Parishin decreases CD38 in naturally aged mice.

    “Notably, we found that parishin treatment led to a reduction in Cluster of differentiation 38 (CD38) levels”

    Animalsin naturally aged mice

    Parishin Alleviates Pulmonary Fibrosis by Reducing CD38 Levels in Naturally Aging Mice

    Rejuvenation research

More on Parishin

Astragalin

downin zebrafish1

1 study
  1. Astragalin inhibits CD38 in oxidatively damaged zebrafish embryos.

    “via the suppression of CD38 enzymatic activity”

    Animalsin oxidatively damaged zebrafish embryos

    Astragalin from Thesium chinense: A Novel Anti-Aging and Antioxidant Agent Targeting IGFR/CD38/Sirtuins

    Antioxidants (Basel, Switzerland)

More on Astragalin

LAV-BPIFB4

downin mice1

1 study
  1. LAV-BPIFB4 prevents CD38 in old mice, relative to untreated old mice.

    “by preventing the NADase CD38 increase in F4/80+ tissue-resident macrophages and Ly6Chigh pro-inflammatory monocytes of the spleen and bone marrow”

    Animalsin old mice, relative to untreated old miceAAV-mediated gene transferspleen and bone marrow

    Transfer of the longevity-associated variant of BPIFB4 gene rejuvenates immune system and vasculature by a reduction of CD38⁺ macrophages and NAD⁺ decline

    Cell death & disease

More on LAV-BPIFB4

All 13

Effects

64

NAD+

downin reviews5downin mice4downin cells3downin human cells1

13 studies
  1. CD38 decreases NAD+.

    “and consumption by enzymes like sirtuins, PARPs, and CD38”

    Review

    Targeting NAD Homeostasis: Compartmentalization, Quantification, and Modulation

    Metabolites

  2. CD38 decreases NAD+ in mice (shown by genetic ablation).

    “where it depletes NAD+”

    Animalsshown by genetic ablationchoroid plexus

    CD38 Inhibition Ameliorates Age-Related CognitiveDecline via a Choroid Plexus-Cerebrospinal Fluid-Hippocampus Axis

    Research squarePreprint

  3. CD38 decreases NAD+ in mice (myeloid-derived CD38).

    “CD38 derived from myeloid serves as a principal driver of uterine NAD+ depletion”

    Animalsmyeloid-derived CD38uterus

    Myeloid-Derived CD38 Mediates Age-Related Endometrial Aging Through NAD⁺ Depletion

    Aging cell

  4. CD38 decreases NAD+.

    “With advancing age, the expression of CD38 tends to increase, leading to reduced NAD + levels.”

    Review

    CD38-NAD(+) Axis: New Insights into Glaucoma Therapy

    Molecular neurobiology

  5. CD38 decreases NAD+ in cells (upregulated via liver X receptor by metabolic and genotoxic stress).

    “upregulate CD38 to promote lysosomal cholesterol efflux, leading to nicotinamide adenine dinucleotide (NAD+) depletion in macrophages”

    Cellsupregulated via liver X receptor by metabolic and genotoxic stressmacrophages

    LXR/CD38 activation drives cholesterol-induced macrophage senescence and neurodegeneration via NAD⁺ depletion

    Cell reports

  6. CD38 decreases NAD+.

    “We also describe the role of PARPs and CD38 as important NAD+ consumers”

    Review

    The Role of NAD⁺ in Metabolic Regulation of Adipose Tissue: Implications for Obesity-Induced Insulin Resistance

    Biomedicines

  7. CD38 decreases NAD+ in endothelial cells, by reducing NMN bioavailability.

    “Upregulation of CD38 in endothelial cells led to endothelial NAD+ exhaustion by reducing NMN bioavailability.”

    Cellsin endothelial cells, by reducing NMN bioavailabilityendothelial cells

    NAD⁺ exhaustion by CD38 upregulation contributes to blood pressure elevation and vascular damage in hypertension

    Signal transduction and targeted therapy

  8. CD38 decreases NAD+.

    “CD38 is the main NAD+-degrading enzyme”

    Review

    The Role of CD38 in the Pathogenesis of Cardiorenal Metabolic Disease and Aging, an Approach from Basic Research

    Cells

  9. CD38 decreases NAD+ in human cells (CD38 overexpression).

    “CD38 overexpression also dramatically reduced intracellular NAD+ levels and decreased mitochondrial respiration as measured by oxygen consumption rate.”

    CellsCD38 overexpressionLNCaP95 cell

    CD38-Induced Apoptosis and Mitochondrial Damage is Restored by Nicotinamide in Prostate Cancer

    Frontiers in molecular biosciences

  10. CD38 decreases NAD+ in cells.

    “CD38 was found to reduce NAD+ levels and sirtuin activity to augment cellular fibrotic responses”

    Cells

    Targeting CD38-dependent NAD⁺ metabolism to mitigate multiple organ fibrosis

    iScience

All 13

More on NAD+

Cellular senescence

upin mice3upin human cells2upin animals1

6 studies
  1. CD38 increases cellular senescence in human cells (shown by knockdown under oxidative stress).

    “In human umbilical vein endothelial cells cultures, CD38 knockdown attenuated oxidative stress-induced senescence and cellular injury markers”

    Cellsshown by knockdown under oxidative stressHUVEC

    Blocking CD38 reduces lung transplant injury in mice

    Research SquarePreprint

  2. CD38 increases cellular senescence (shown by pharmacological and genetic approaches).

    “macrophage CD38 depletes NAD+ in decidual stromal cells, thereby promoting placental senescence”

    Animalsshown by pharmacological and genetic approachesplacenta

    Macrophage CD38 drives age-related placental senescence by depleting NAD⁺

    Nature communications

  3. CD38 increases cellular senescence in mice.

    “promotes cellular senescence”

    Animalschoroid plexus

    CD38 Inhibition Ameliorates Age-Related CognitiveDecline via a Choroid Plexus-Cerebrospinal Fluid-Hippocampus Axis

    Research squarePreprint

  4. CD38 increases cellular senescence in mice (via uterine NAD+ depletion).

    “this process accelerates stromal senescence and impairs uterine receptivity.”

    Animalsvia uterine NAD+ depletionuterus

    Myeloid-Derived CD38 Mediates Age-Related Endometrial Aging Through NAD⁺ Depletion

    Aging cell

  5. CD38 increases cellular senescence in human cells.

    “Notably, we found that the elevated CD38 expression on B cells is a key factor driving B cell senescence, mitochondrial dysfunction, and increased transitional B cell proportion”

    CellsB cells

    Senescent B cells regulate CD38 expression via FOXO1 in pneumonia resulting from PIK3CD (R437C) mutations

    Life medicine

  6. CD38 increases cellular senescence in mice.

    “We discovered a pivotal role of CD38, a cardinal nicotinamide adenine dinucleotide (NAD) hydrolase, in AEC aging and its promotion of lung fibrosis.”

    Animalsalveolar epithelial cells

    CD38 Mediates Lung Fibrosis by Promoting Alveolar Epithelial Cell Aging

    American journal of respiratory and critical care medicine

More on Cellular senescence

Inflammation

upin mice3upin animals1

4 studies
  1. CD38 increases inflammation in mice (shown by deletion or inhibition in bronchoalveolar lavage fluid and plasma).

    “CD38 deletion or inhibition reduced inflammatory cytokines and cellular injury markers.”

    Animalsshown by deletion or inhibition in bronchoalveolar lavage fluid and plasma

    Blocking CD38 reduces lung transplant injury in mice

    Research SquarePreprint

  2. CD38 increases inflammation (STING-driven CD38 upregulation).

    “this STING-driven upregulation of CD38 not only amplifies bone marrow inflammation”

    AnimalsSTING-driven CD38 upregulationbone marrow

    Immune protein has opposing roles in bone as animals age

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)

  3. CD38 increases inflammation in mice (shown by genetic ablation and pharmacological inhibition).

    “reduced inflammatory signaling”

    Animalsshown by genetic ablation and pharmacological inhibitioncsf

    CD38 Inhibition Ameliorates Age-Related CognitiveDecline via a Choroid Plexus-Cerebrospinal Fluid-Hippocampus Axis

    Research squarePreprint

  4. CD38 increases inflammation in mice (shown by knockout; LPS-induced).

    “Deletion of CD38 decreased LPS-induced inflammatory responses and glial activation.”

    Animalsshown by knockout; LPS-induced

    Inhibition of CD38 and supplementation of nicotinamide riboside ameliorate lipopolysaccharide-induced microglial and astrocytic neuroinflammation by increasing NAD

    Journal of neurochemistry

More on Inflammation

Ischemia-reperfusion injury

upin mice2

2 studies
  1. CD38 increases ischemia-reperfusion injury in mice (shown by genetic deletion or pharmacologic inhibition in murine hilar clamp lung IRI model).

    “genetic deletion or pharmacologic inhibition of CD38 preserved NAD+ levels, attenuated SASP-associated inflammatory mediators, reduced histologic lung injury, and improved pulmonary mechanics.”

    Animalsshown by genetic deletion or pharmacologic inhibition in murine hilar clamp lung IRI modellung

    Blocking CD38 reduces lung transplant injury in mice

    Research SquarePreprint

  2. CD38 increases ischemia-reperfusion injury in mice (shown by conditional deletion in Kupffer cells).

    “conditional deletion of CD38 in Kupffer ells partially alleviated these changes in vivo and in vitro”

    Animalsshown by conditional deletion in Kupffer cellsKupffer cells

    NLR family pyrin domain containing 3-mediated Kupffer cell pyroptosis aggravates ischemia-reperfusion injury after aging donor liver transplantation through CD38-nicotinamide adenine dinucleotide⁺-sirtuin 1-dependent acetylation of estrogen-related receptor α

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

More on Ischemia-reperfusion injury

SIRT1

downin mouse cells1downin reviews1

2 studies
  1. CD38 inhibits SIRT1 (proposed mechanism via NAD+ depletion).

    “CD38-mediated NAD+ depletion inactivates SIRT1, which removes inhibition of NF-κB”

    Reviewproposed mechanism via NAD+ depletion

    Tryptophan metabolism regulates immunosenescence and inflammaging: The macrophage immunometabolic axis and therapeutic targets

    Ageing research reviews

  2. CD38 inhibits SIRT1 in vitro incubation with purified recombinant SIRT1 (significant inhibition of SIRT1 activity).

    “incubation of purified recombinant SIRT1 enzyme with CD38 or nuclear extracts of wild-type mice led to a significant inhibition of its activity”

    Cellsin vitro incubation with purified recombinant SIRT1recombinant protein

    Regulation of SIRT 1 mediated NAD dependent deacetylation: a novel role for the multifunctional enzyme CD38

    Biochemical and biophysical research communications

More on SIRT1

SUOX

downin cells1downin mouse cells1

2 studies
  1. CD38 inhibits SUOX in mouse cells.

    “CD38 suppressed SUOX, demonstrated a switch into the reverse mode of mitochondrial complex V”

    Cells

    Gene loss promoted clots inside artery plaques in mice

    Circulation research

  2. CD38 decreases SUOX in cells (CD38 upregulation).

    “CD38 upregulation was found to suppress SUOX expression”

    CellsCD38 upregulation

    Downregulation of LATS1/2 Drives Endothelial Senescence-Associated Stemness (SAS) and Atherothrombotic Lesion Formation

    bioRxiv : the preprint server for biologyPreprint

More on SUOX

Cellular NAD+

downin mammalian1downin reviews1

2 studies
  1. CD38 decreases cellular NAD+ during aging, inflammation, and tumor growth.

    “Through rapid hydrolytic degradation of NAD+, CD38 drives cellular NAD+ depletion during aging, inflammation, and tumor growth, contributing to mitochondrial dysfunction and immune suppression.”

    Reviewduring aging, inflammation, and tumor growth

    Emerging chemical strategies for CD38 inhibition: restoring NAD⁺ metabolism and disease control

    Bioorganic & medicinal chemistry

  2. CD38 decreases cellular NAD+ in mammalian.

    “CD38 was also identified as one of the main cellular NADases in mammalian tissues and appears to regulate cellular levels of NAD”

    Review

    CD38 as a regulator of cellular NAD: a novel potential pharmacological target for metabolic conditions

    Current pharmaceutical design

More on Cellular NAD+

NAD+

downin humans1downin reviews1

2 studies
  1. CD38 decreases NAD in humans.

    “CD38, as a major NAD-depleting enzyme, is pivotal in regulating intracellular NAD levels and various physiological processes.”

    Review

    Unveiling the role of NAD glycohydrolase CD38 in aging and age-related diseases: insights from bibliometric analysis and comprehensive review

    Frontiers in immunology

  2. CD38 decreases NAD.

    “CD38-dependent NAD decline is often a common denominator of pathophysiology”

    Review

    The CD38 glycohydrolase and the NAD sink: implications for pathological conditions

    American journal of physiology. Cell physiology

Intracellular NAD+

downin mouse cells1mediatesin reviews1

2 studies
  1. CD38 decreases intracellular NAD+ in mouse cells.

    “CD38 elevation downregulated intracellular NAD”

    Cellsalveolar epithelial cells

    CD38 Mediates Lung Fibrosis by Promoting Alveolar Epithelial Cell Aging

    American journal of respiratory and critical care medicine

  2. CD38 mediates intracellular NAD+ in tumor immunity.

    “We also discuss the paradoxical role of CD38 as a modulator of intracellular NAD+, particularly in tumor immunity.”

    Reviewin tumor immunity

    The Multi-faceted Ecto-enzyme CD38: Roles in Immunomodulation, Cancer, Aging, and Metabolic Diseases

    Frontiers in immunology

More on Intracellular NAD+

Nicotinamide mononucleotide availability

downin animals1

1 study
  1. CD38 decreases nicotinamide mononucleotide availability (STING-driven CD38 upregulation).

    “depletes the precursor nicotinamide mononucleotide (NMN) required for NAD+ salvage synthesis, thereby impairing NMN availability and osteogenic capacity in neighboring bone marrow mesenchymal stem cells.”

    AnimalsSTING-driven CD38 upregulationbone marrow mesenchymal stem cell

    Immune protein has opposing roles in bone as animals age

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)

More on Nicotinamide mononucleotide availability

All 64

Upstream

2

Inflammation

upin mice1upin reviews1

2 studies
  1. Inflammation induces CD38 in mice (earlier onset of inflammation in the ovary).

    “the earlier onset of inflammation induced higher expression levels of CD38 and decreased NAD+ levels in the ovary”

    Animalsearlier onset of inflammation in the ovaryovaryfemales

    NADase CD38 is a key determinant of ovarian aging

    Nature aging

  2. Inflammation activates CD38 with aging.

    “CD38 is activated in response to inflammation with aging”

    Reviewwith aging

    The Role of CD38 in the Pathogenesis of Cardiorenal Metabolic Disease and Aging, an Approach from Basic Research

    Cells

More on Inflammation

IL-1β

upin cells1

1 study
  1. IL-1β increases CD38 in cells (via JAK1-STAT1 signaling, from pro-inflammatory macrophages).

    “Pro-inflammatory macrophages infiltration and increase in IL-1β generation derived from pro-inflammatory macrophages resulted in higher CD38 expression by activating JAK1-STAT1 signaling pathway.”

    Cellsvia JAK1-STAT1 signaling, from pro-inflammatory macrophages

    NAD⁺ exhaustion by CD38 upregulation contributes to blood pressure elevation and vascular damage in hypertension

    Signal transduction and targeted therapy

Associations

24

Age-related diseases

mixedin reviews1upin reviews1

2 studies
  1. CD38 is associated with age-related diseases.

    “key findings highlighted the critical role of CD38 in aging and age-related diseases”

    Review

    Unveiling the role of NAD glycohydrolase CD38 in aging and age-related diseases: insights from bibliometric analysis and comprehensive review

    Frontiers in immunology

  2. CD38 is associated with age-related diseases (altered CD38 enzymatic activity in animal models).

    “in animal models the development of infectious diseases, autoimmune disorders, fibrosis, metabolic diseases, and age-associated diseases including cancer, heart disease, and neurodegeneration are associated with altered CD38 enzymatic activity”

    Reviewaltered CD38 enzymatic activity in animal models

    The CD38 glycohydrolase and the NAD sink: implications for pathological conditions

    American journal of physiology. Cell physiology

More on Age-related diseases

Senescence-associated secretory phenotype (SASP)

upin human cells1

1 study
  1. CD38 is associated with senescence-associated secretory phenotype (SASP) in donor lungs.

    “CD38 expression increased with donor age and ischemic stress, particularly in donation after circulatory death (DCD) allografts, and was associated with senescence-associated secretory phenotype (SASP) signaling.”

    Cellsin donor lungslung

    Blocking CD38 reduces lung transplant injury in mice

    Research SquarePreprint

More on Senescence-associated secretory phenotype (SASP)

Intracellular NAD+

downin reviews1

1 study
  1. CD38 is associated with intracellular NAD+ (CD38 overexpression during aging and menopause).

    “chronic inflammation and CD38 overexpression appear strongly associated with progressive intracellular NAD+ depletion during aging and menopause”

    ReviewCD38 overexpression during aging and menopause

    Nicotinamide Adenine Dinucleotide and Its Anti-aging Effects in the Context of Longevity and Menopause

    Mini reviews in medicinal chemistry

More on Intracellular NAD+

NAD+ metabolism

upin reviews1

1 study
  1. CD38 is associated with NAD+ metabolism (aging).

    “aging reshapes these circuits through CD38 upregulation”

    Reviewaging

    NAD⁺ circuits in aging, tissue repair and fibrosis

    Ageing research reviews

More on NAD+ metabolism

triglyceride/HDL cholesterol ratio

upin humans1

1 study
  1. triglyceride/HDL cholesterol ratio is associated with CD38 in humans (individuals without known cardiac disease).

    “The TG/HDL-C ratio showed a positive correlation with TMAO and CD38 levels.”

    Humansindividuals without known cardiac diseasemonocyten = 82

    Investigation of the relationship between trimethylamine N-oxide, CD36, and CD38 levels in individuals with a high triglyceride/HDL-cholesterol ratio

    Scandinavian journal of clinical and laboratory investigation

More on triglyceride/HDL cholesterol ratio

Dyslipidemia

upin humans1

1 study
  1. Dyslipidemia is associated with CD38 in humans (dyslipidemic individuals compared with healthy controls).

    “The TG/HDL-C ratio, TMAO level, and CD38 expressions were significantly higher in the dyslipidemia group compared to the control group (p < 0.05).”

    Humansdyslipidemic individuals compared with healthy controlsmonocyten = 82

    Investigation of the relationship between trimethylamine N-oxide, CD36, and CD38 levels in individuals with a high triglyceride/HDL-cholesterol ratio

    Scandinavian journal of clinical and laboratory investigation

More on Dyslipidemia

Cellular senescence

mixedin mice1

1 study
  1. CD38 is associated with cellular senescence in mice (shown by knockout (Cd38+/- and Cd38-/- mice)).

    “alterations in mitochondrial, metabolic, senescence-related, astrocyte reactivity, and other genes involved in PD and AD etiology”

    Animalsshown by knockout (Cd38+/- and Cd38-/- mice)astrocytes

    Novel Roles for the Ectoenzyme CD38 in the Maintenance of Transcriptional and Metabolic Homeostasis in Astrocytes

    Glia

More on Cellular senescence

Midbrain astrocytes

upin mice1

1 study
  1. CD38 is associated with midbrain astrocytes in mice.

    “we demonstrate enrichment of Cd38 in midbrain astrocytes”

    Animalsmidbrain astrocytes

    Novel Roles for the Ectoenzyme CD38 in the Maintenance of Transcriptional and Metabolic Homeostasis in Astrocytes

    Glia

Bone marrow inflammaging

upin mice1

1 study
  1. CD38 is associated with bone marrow inflammaging in different mouse models.

    “Increased expression of CD38 and Ly6a, and decreased expression of Col1a and Lif in macrophages serve as shared changes in different mouse models.”

    Animalsin different mouse modelsmacrophages

    Single-cell transcriptomics identifies the common perturbations of monocyte/macrophage lineage cells in inflammaging of bone marrow

    Journal of orthopaedic translation

5'-azido nicotinamide riboside

upin cells1

1 study
  1. 5'-azido nicotinamide riboside is associated with CD38 in cells (covalent labeling of extracellular and intracellular CD38 in live cells).

    “This cell-permeable NR analogue enables covalent labeling and imaging of both extracellular and intracellular CD38 in live cells.”

    Cellscovalent labeling of extracellular and intracellular CD38 in live cellsazido substitution at the 5'-OH position

    Nicotinamide Riboside and CD38: Covalent Inhibition and Live-Cell Labeling

    JACS Au

More on 5'-azido nicotinamide riboside

All 24

Funding

9 grants since 2018

National Institute on Aging$3.3MJapan Society for the Promotion of Science¥7.4MNational Institute of Dental and Craniofacial Research$415K

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    A study in human placenta reports that CD38 increases cellular senescence. A mouse preprint reports reduced CD38 in CD8-positive T cells with nicotinamide riboside during T. cruzi infection.

  2. Summary written from the findings.

Latest

Dec 2025: 6Jan 2026: 7Feb 2026: 2Mar 2026: 4Apr 2026: 3May 2026: 2Jun 2026: 4Jul 2026: 4Aug 2026: 5Sep 2026: 3Oct 2026: 9Nov 2026: 554 papers in 12 months
Cell Reports

Clearing protein deposits restored liver regrowth in aged mice

Experiments in aged mice found that clearing abnormal protein deposits around blood vessels with anselamimab restored liver regeneration after partial liver removal.Experiments in aged mice found that clearing abnormal protein deposits around blood vessels with anselamimab restored liver regeneration after partial liver removal.

Mouse studyInterventions
bioRxiv

Imaging links kidney structure to molecular aging in rats

Image-based age estimates differed from actual ages by a mean absolute error of 0.78 months in rats excluded from model training.Image-based age estimates differed from actual ages by a mean absolute error of 0.78 months in rats excluded from model training.

Preprint: rat study · 32 ratsBiomarkers
Analytical Chemistry

Blood immune cell patterns linked to age in Chinese people

An observational study of 605 healthy people found age-related patterns in blood immune cells and links between estimated immune age and lifestyle.An observational study of 605 healthy people found age-related patterns in blood immune cells and links between estimated immune age and lifestyle.

Cross-sectional · 605 peopleBlood and immune system
Research Square

Blocking CD38 reduces lung transplant injury in mice

Targeting the enzyme preserved NAD⁺ levels, lowered signs of cellular senescence, and improved lung function after blood flow was stopped and restored.Targeting the enzyme preserved NAD⁺ levels, lowered signs of cellular senescence, and improved lung function after blood flow was stopped and restored.

Preprint: mouse studyCD38

See all 248 papers on CD38